The AMR Challenge is a way for organizations around the world to collaborate in the fight against antimicrobial resistance. When the challenge launched, bioMérieux made three commitments to the fight against antimicrobial resistance.
“I thought of sepsis with elderly patients and immunocompromised patients, but that’s just not true,” said Meyers. “It can happen to you; it can happen to your daughter; it can happen to a perfectly healthy individual; it can happen to anyone.”
Reduction in sepsis mortality is directly dependent on early identification and rapid initiation of appropriate antimicrobial therapy. Fast and accurate diagnosis may also shorten the length of a hospital stay and potentially help reduce the emergence of multidrug-resistant bacteria.